ALGS Stock Analysis: Buy, Sell, or Hold?
ALGS - Aligos Therapeutics, Inc. Common Stock
$5.65
-0.04 (-0.70%)
▼
5d:
+10.57%
30d:
-1.05%
90d:
-17.76%
BUY
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When ALGS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ALGS shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: ALGS shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: ALGS is currently trading at $5.65, which is considered extended relative to its 30-day fair value range of $5.10 to $5.64.
Technical Outlook: Technically, ALGS is in a strong downtrend. Immediate support is located at $4.91, while resistance sits at $5.94.
Market Sentiment: ALGS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $56.29 (+896.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ALGS is in a strong downtrend. Immediate support is located at $4.91, while resistance sits at $5.94.
Market Sentiment: ALGS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $56.29 (+896.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$5.10 -
$5.64
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 896.2% below Wall St target ($56.29)
Trading Range Analysis
30-Day Trading Range
$5.10 -
$5.64
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$4.91
Resistance Level
$5.94
Current Trend
Strong Downtrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.41
Wall Street Target
$56.29
(+896.2%)
Revenue Growth (YoY)
810.0%
Share & Embed Analysis
Last updated: June 24, 2026 12:12 AM ET
Data refreshes hourly during market hours. Next update: 1:12 AM
Data refreshes hourly during market hours. Next update: 1:12 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALGS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 64 BUY |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 62 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 65 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 61 BUY |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$109 | 60 BUY |
